Orexo US Inc.

Parsippany-Troy Hills, NJ

UEI
MN1MPMBCVVD5
CAGE
6Y7L3
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1 Gatehall Dr #309, Parsippany, NJ 07054, USA
Website
orexo.com
Founded
1995
Employees
51-250
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Orexo US Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Clinical development of OX390 (atipamezole) as an ?2 agonist reversal agent for human use to counteract the sedative… Contract · 75A50125C00010 Office of the Assistant Secretary for Preparedness and Response $11,450,712

Contract vehicles

Orexo US Inc. holds a place on 1 federal contract vehicle. Active vehicles first.

Quick answers

What is Orexo US Inc.'s UEI?

Orexo US Inc.'s Unique Entity ID (UEI) in SAM.gov is MN1MPMBCVVD5.

What is Orexo US Inc.'s CAGE code?

Orexo US Inc.'s CAGE code is 6Y7L3.

What is Orexo US Inc.'s primary NAICS code?

Orexo US Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Orexo US Inc. located?

Orexo US Inc.'s physical address in SAM.gov is 1 Gatehall Dr #309, Parsippany, NJ 07054, USA.

Is Orexo US Inc. registered in SAM.gov?

Yes. Orexo US Inc.'s SAM.gov registration is active through April 23, 2027.

Which contract vehicles does Orexo US Inc. hold?

Orexo US Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Orexo US Inc.'s most recent federal award?

Orexo US Inc.'s most recent federal contract award is Clinical development of OX390 (atipamezole) as an ?2 agonist reversal agent for human use to counteract the sedative… (75A50125C00010), from Office of the Assistant Secretary for Preparedness and Response, on September 24, 2025.

On GovTribe

See Orexo US Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login